Published date: 27 February 2017

Last edited date: 27 February 2017

This notice was replaced on 27 February 2017

This notice does not contain the most up-to-date information about this procurement. The most recent notice is:

Awarded contract (published 27 February 2017)

Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.


Contract summary

Industry

  • Disposable non-chemical medical consumables and haematological consumables - 33141000

Location of contract

North East, North West, Yorkshire and the Humber, East Midlands, West Midlands, East of England, London, South East, South West

Value of contract

£200,000

Procurement reference

ITT_1037

Published date

27 February 2017

Closing date

19 July 2016

Contract start date

1 December 2016

Contract end date

30 November 2020

Contract type

Supply contract

Procedure type

Open procedure

Any interested supplier may submit a tender in response to an opportunity notice.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

No


Description

NHS Blood and Transplant is issuing this invitation to tender in connection with the competitive procurement of Cord Blood Collection Systems. This document contains important information about the Procurement Process and the Contract that the Authority intends to award.

The NHS Cord Blood Bank collects cord blood at six NHS hospitals; and is the fourth largest internationally accredited cord blood bank in the world, with the second highest percentage of rare tissue types.

Cord blood is collected Ex Utero from the umbilical cord following delivery of a baby and taken to a regulated area, where the cord blood is collected into a purpose designed bag (i.e. a Cord Blood Collection System). Once a successful collection is completed the cord blood unit is stored in a temperature controlled environment until it is transported to the Authority's evaluation facility in Colindale and then the Authority's processing facility at Filton. Cord blood is rich in stem cells and once processed can be used to treat patients who are suffering from life threatening diseases, including malignancies, bone marrow failure, haemoglobinopathies, immunodeficiencies and metabolic disorders.


More information

Attachments

Links


About the buyer

Contact name

Daniel Kirkbride

Address

500 North Bristol Park
Northway, Filton
Bristol
BS34 7QH
England

Telephone

01179217244

Email

daniel.kirkbride@nhsbt.nhs.uk

Website

https://nhsbt.bravosolution.co.uk/web/login.shtml